Russell Investments Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Russell Investments Group’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-23,241	Closed	-$417K	–	3319
2020 Q2	$417K	Sell	23,241 -105,746	-82%	-$1.47M	﹤0.01%	2446
2020 Q1	$919K	Buy	128,987 +77,791	+152%	+$971K	﹤0.01%	1882
2019 Q4	$1.22M	Buy	+51,196	New	+$1.41M	﹤0.01%	2008
2019 Q1	–	Sell	-285,165	Closed	-$5.46M	–	3074
2018 Q4	$5.46M	Buy	285,165 +44,502	+18%	+$915K	0.01%	1103
2018 Q3	$6.41M	Buy	240,663 +111,663	+87%	+$3.65M	0.01%	1174
2018 Q2	$4.87M	Buy	129,000 +52,148	+68%	+$1.99M	0.01%	1298
2018 Q1	$2.51M	Buy	76,852 +69,883	+1,003%	+$3.07M	﹤0.01%	1711
2017 Q4	$329K	Sell	6,969 -3,873	-36%	-$196K	﹤0.01%	2562
2017 Q3	$586K	Sell	10,842 -7,797	-42%	-$458K	﹤0.01%	2382
2017 Q2	$1.05M	Buy	+18,639	New	+$747K	﹤0.01%	2087

Russell Investments Group's PTLA Position: Q3 2020 in Review

Russell Investments Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 23,241 shares — an estimated $417K sold.

Russell Investments Group first reported a position in PTLA in Q2 2017 and held it in 10 quarters. The position peaked at $6.41M in Q3 2018. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Russell Investments Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Russell Investments Group sold 23,241 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $417K.
Russell Investments Group first reported a position in Portola Pharmaceuticals, Inc. in Q2 2017 and held it in 10 quarters.
Russell Investments Group's Portola Pharmaceuticals, Inc. position peaked at $6.41M in Q3 2018.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Russell Investments Group's 13F filing for Q3 2020, filed 9 Nov 2020.